Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
Lancet Infect. Dis.
; 2020.
Article
in En
| SES-SP, SESSP-IBPROD, SES-SP
| ID: but-ib17572
Responsible library:
BR78.1
Localization: BR78.1
Full text:
1
Collection:
06-national
/
BR
Database:
SES-SP
/
SESSP-IBPROD
Language:
En
Journal:
Lancet Infect. Dis.
Year:
2020
Document type:
Article